Compounds > acetaminophen
Page last updated: 2024-10-22

acetaminophen and Sinus Infections

acetaminophen has been researched along with Sinus Infections in 16 studies

Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.

Research Excerpts

ExcerptRelevanceReference
"Tiaprofenic acid (Surgam) is a non steroidal anti-inflammatory drug used for acute inflammation during episode of upper respiratory tract infection in adults."6.67[Efficacy and tolerability of tiaprofenic acid (Surgam) in acute sinusitis in adults. Results of a randomized study versus paracetamol and placebo]. ( Frachet, B; Genes, N; Rezvani, Y, 1991)
" We sought to evaluate the effectiveness and safety of over the counter dosing of ibuprofen on pain and bleeding rates following ESS."5.56Effect of Over the Counter Ibuprofen Dosing after Sinus Surgery for Chronic Rhinosinusitis: A Prospective Cohort Pilot Study. ( Davis, GE; Humphreys, IM; Miller, C, 2020)
"The primary outcome was postoperative pain measured by visual analog scale (VAS) scores up to 24 hours after surgery by blinded observers."2.84Analgesic Effects of Intravenous Acetaminophen vs Placebo for Endoscopic Sinus Surgery and Postoperative Pain: A Randomized Clinical Trial. ( Ashoori, F; Cai, C; Cattano, D; Citardi, MJ; Fakhri, S; Kain, JJ; Lam, K; Luong, A; Tyler, MA, 2017)
"We sought to study postoperative pain after endoscopic sinus surgery and to evaluate the efficacy of dexamethasone sodium phosphate in reducing pain and rescue analgesic requirements."2.75Role of dexamethasone in reducing pain after endoscopic sinus surgery in adults: a double-blind prospective randomized trial. ( Al-Qudah, M; Rashdan, Y, 2010)
"Tiaprofenic acid (Surgam) is a non steroidal anti-inflammatory drug used for acute inflammation during episode of upper respiratory tract infection in adults."2.67[Efficacy and tolerability of tiaprofenic acid (Surgam) in acute sinusitis in adults. Results of a randomized study versus paracetamol and placebo]. ( Frachet, B; Genes, N; Rezvani, Y, 1991)
" We sought to evaluate the effectiveness and safety of over the counter dosing of ibuprofen on pain and bleeding rates following ESS."1.56Effect of Over the Counter Ibuprofen Dosing after Sinus Surgery for Chronic Rhinosinusitis: A Prospective Cohort Pilot Study. ( Davis, GE; Humphreys, IM; Miller, C, 2020)

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19905 (31.25)18.7374
1990's2 (12.50)18.2507
2000's2 (12.50)29.6817
2010's4 (25.00)24.3611
2020's3 (18.75)2.80

Authors

AuthorsStudies
Miller, C1
Humphreys, IM1
Davis, GE1
Ayoub, NF1
Choby, G1
Turner, JH1
Abuzeid, WM1
Raviv, JR1
Thamboo, A1
Ma, Y1
Chandra, RK1
Chowdhury, NI1
Stokken, JK1
O'Brien, EK1
Shah, S1
Akbar, N1
Roozdar, P1
Nayak, JV1
Patel, ZM1
Hwang, PH1
Tyler, MA1
Lam, K1
Ashoori, F1
Cai, C1
Kain, JJ1
Fakhri, S1
Citardi, MJ1
Cattano, D1
Luong, A1
Umstattd, LA1
Dooley, LM1
Leykin, Y1
Casati, A1
Rapotec, A1
Dalsasso, M1
Barzan, L1
Fanelli, G1
Pellis, T1
Sultész, M1
Katona, G1
Hirschberg, A1
Gálffy, G1
Al-Qudah, M1
Rashdan, Y1
Finkensieper, M1
Poller, K1
Wittekindt, C1
Meissner, W1
Guntinas-Lichius, O1
Rallis, E1
Balatsouras, DG1
Kouskoukis, C1
Verros, C1
Homsioglou, E1
Penalba, C1
Eugene, C1
Leger, F1
Machet, L1
Jan, V1
Machet, C1
Lorette, G1
Vaillant, L1
Spector, SL1
Wangaard, CH1
Farr, RS1
Frachet, B1
Genes, N1
Rezvani, Y1
Aleixo, PL1
Monteiro, PR1
da Silva, AC1
Peter, M1
Matts, SG1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Multi-institutional, Randomized Controlled Trial Assessing Opioid Use and Analgesic Requirements After Endoscopic Sinus Surgery[NCT03783702]Phase 4118 participants (Actual)Interventional2019-04-04Completed
A Double Blind, Randomized, Placebo-controlled Study to Investigate the Effectiveness of IV Acetominophen Administered During Functional Endoscopic Sinus Surgery in Reducing the Use of Opiates to Treat Postoperative Pain[NCT01608308]62 participants (Actual)Interventional2012-07-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Brief Pain Inventory (BPI) Score

"The Brief Pain Inventory (BPI) Severity short form is a validated, patient-reported outcome measure that assesses pain over a 24-hour period. The Pain Severity score is calculated as a composite mean score using the degree of pain a patient experiences per day at its least, worst, average, and now. The score ranges from 0 to 10 (higher indicates more pain).~Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain 2004. 20(5): 309-318." (NCT03783702)
Timeframe: Average BPI score will be collected for postoperative day 1

Interventionunits on a scale (Mean)
Experimental Group2.8
Control Group2.9

Brief Pain Inventory (BPI) Score

"The Brief Pain Inventory (BPI) Severity short form is a validated, patient-reported outcome measure that assesses pain over a 24-hour period. The Pain Severity score is calculated as a composite mean score using the degree of pain a patient experiences per day at its least, worst, average, and now. The score ranges from 0 to 10 (higher indicates more pain).~Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain 2004. 20(5): 309-318." (NCT03783702)
Timeframe: Average BPI score will be collected for postoperative day 2

Interventionunits on a scale (Mean)
Experimental Group2.5
Control Group2.3

Brief Pain Inventory (BPI) Score

"The Brief Pain Inventory (BPI) Severity short form is a validated, patient-reported outcome measure that assesses pain over a 24-hour period. The Pain Severity score is calculated as a composite mean score using the degree of pain a patient experiences per day at its least, worst, average, and now. The score ranges from 0 to 10 (higher indicates more pain).~Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain 2004. 20(5): 309-318." (NCT03783702)
Timeframe: Average BPI score will be collected for postoperative day 3

Interventionunits on a scale (Mean)
Experimental Group1.9
Control Group2.1

Brief Pain Inventory (BPI) Score

"The Brief Pain Inventory (BPI) Severity short form is a validated, patient-reported outcome measure that assesses pain over a 24-hour period. The Pain Severity score is calculated as a composite mean score using the degree of pain a patient experiences per day at its least, worst, average, and now. The score ranges from 0 to 10 (higher indicates more pain).~Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain 2004. 20(5): 309-318." (NCT03783702)
Timeframe: Average BPI score will be collected for postoperative day 4

Interventionunits on a scale (Mean)
Experimental Group1.5
Control Group1.9

Brief Pain Inventory (BPI) Score

"The Brief Pain Inventory (BPI) Severity short form is a validated, patient-reported outcome measure that assesses pain over a 24-hour period. The Pain Severity score is calculated as a composite mean score using the degree of pain a patient experiences per day at its least, worst, average, and now. The score ranges from 0 to 10 (higher indicates more pain).~Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain 2004. 20(5): 309-318." (NCT03783702)
Timeframe: Average BPI score will be collected for postoperative day 5

Interventionunits on a scale (Mean)
Experimental Group1.7
Control Group1.6

Brief Pain Inventory (BPI) Score

"The Brief Pain Inventory (BPI) Severity short form is a validated, patient-reported outcome measure that assesses pain over a 24-hour period. The Pain Severity score is calculated as a composite mean score using the degree of pain a patient experiences per day at its least, worst, average, and now. The score ranges from 0 to 10 (higher indicates more pain).~Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain 2004. 20(5): 309-318." (NCT03783702)
Timeframe: Average BPI score will be collected for postoperative day 6

Interventionunits on a scale (Mean)
Experimental Group1.5
Control Group1.4

Brief Pain Inventory (BPI) Score

"The Brief Pain Inventory (BPI) Severity short form is a validated, patient-reported outcome measure that assesses pain over a 24-hour period. The Pain Severity score is calculated as a composite mean score using the degree of pain a patient experiences per day at its least, worst, average, and now. The score ranges from 0 to 10 (higher indicates more pain).~Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain 2004. 20(5): 309-318." (NCT03783702)
Timeframe: Average BPI score will be collected for postoperative day 7

Interventionunits on a scale (Mean)
Experimental Group1.3
Control Group1.4

Brief Pain Inventory (BPI) Score

"The Brief Pain Inventory (BPI) Severity short form is a validated, patient-reported outcome measure that assesses pain over a 24-hour period. The Pain Severity score is calculated as a composite mean score using the degree of pain a patient experiences per day at its least, worst, average, and now. The score ranges from 0 to 10 (higher indicates more pain).~Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain 2004. 20(5): 309-318." (NCT03783702)
Timeframe: BPI score will be collected at the preoperative visit

Interventionunits on a scale (Mean)
Experimental Group1.6
Control Group1.0

Pain Severity

"A 10-cm visual analog scale (VAS) will be used to assess pain severity.The VAS is a continuous, patient-reported outcome measure determined using a horizontal 100-mm scale ranging from no pain with a score of 0 to worst imaginable pain, corresponding to a score of 100." (NCT03783702)
Timeframe: Average pain score was collected for postoperative day 1

Interventionunits on a scale (Mean)
Experimental Group30.2
Control Group29.4

Pain Severity

"A 10-cm visual analog scale (VAS) will be used to assess pain severity.The VAS is a continuous, patient-reported outcome measure determined using a horizontal 100-mm scale ranging from no pain with a score of 0 to worst imaginable pain, corresponding to a score of 100." (NCT03783702)
Timeframe: Average pain score will be collected for postoperative day 2

Interventionunits on a scale (Mean)
Experimental Group27.0
Control Group23.5

Pain Severity

"A 10-cm visual analog scale (VAS) will be used to assess pain severity.The VAS is a continuous, patient-reported outcome measure determined using a horizontal 100-mm scale ranging from no pain with a score of 0 to worst imaginable pain, corresponding to a score of 100." (NCT03783702)
Timeframe: Average pain score will be collected for postoperative day 3

Interventionunits on a scale (Mean)
Experimental Group19.2
Control Group22.5

Pain Severity

"A 10-cm visual analog scale (VAS) will be used to assess pain severity.The VAS is a continuous, patient-reported outcome measure determined using a horizontal 100-mm scale ranging from no pain with a score of 0 to worst imaginable pain, corresponding to a score of 100." (NCT03783702)
Timeframe: Average pain score will be collected for postoperative day 4

Interventionunits on a scale (Mean)
Experimental Group14.1
Control Group16.8

Pain Severity

"A 10-cm visual analog scale (VAS) will be used to assess pain severity.The VAS is a continuous, patient-reported outcome measure determined using a horizontal 100-mm scale ranging from no pain with a score of 0 to worst imaginable pain, corresponding to a score of 100." (NCT03783702)
Timeframe: Average pain score will be collected for postoperative day 5

Interventionunits on a scale (Mean)
Experimental Group15.8
Control Group15.0

Pain Severity

"A 10-cm visual analog scale (VAS) will be used to assess pain severity.The VAS is a continuous, patient-reported outcome measure determined using a horizontal 100-mm scale ranging from no pain with a score of 0 to worst imaginable pain, corresponding to a score of 100." (NCT03783702)
Timeframe: Average pain score will be collected for postoperative day 6

Interventionunits on a scale (Mean)
Experimental Group13.9
Control Group11.7

Pain Severity

"A 10-cm visual analog scale (VAS) will be used to assess pain severity.The VAS is a continuous, patient-reported outcome measure determined using a horizontal 100-mm scale ranging from no pain with a score of 0 to worst imaginable pain, corresponding to a score of 100." (NCT03783702)
Timeframe: Average pain score will be collected for postoperative day 7

Interventionunits on a scale (Mean)
Experimental Group8.1
Control Group10.1

Pain Severity

"A 10-cm visual analog scale (VAS) will be used to assess pain severity.The VAS is a continuous, patient-reported outcome measure determined using a horizontal 100-mm scale ranging from no pain with a score of 0 to worst imaginable pain, corresponding to a score of 100." (NCT03783702)
Timeframe: Average pain score will be collected for preoperative visit (the day before surgery)

Interventionunits on a scale (Mean)
Experimental Group12.4
Control Group8.5

Severity of Epistaxis

"A 10-cm visual analog scale (VAS) will be used to assess bleeding. The VAS is a continuous, patient-reported outcome measure determined using a horizontal 100-mm scale ranging from no bleeding with a score of 0 to continuous bleeding, corresponding to a score of 100." (NCT03783702)
Timeframe: Epistaxis severity will be collected at the preoperative visit

Interventionunits on a scale (Mean)
Experimental Group0
Control Group0

Severity of Epistaxis

"A 10-cm visual analog scale (VAS) will be used to assess bleeding. The VAS is a continuous, patient-reported outcome measure determined using a horizontal 100-mm scale ranging from no bleeding with a score of 0 to continuous bleeding, corresponding to a score of 100." (NCT03783702)
Timeframe: Epistaxis severity will be collected for postoperative day 1

Interventionunits on a scale (Mean)
Experimental Group36.3
Control Group38.9

Severity of Epistaxis

"A 10-cm visual analog scale (VAS) will be used to assess bleeding. The VAS is a continuous, patient-reported outcome measure determined using a horizontal 100-mm scale ranging from no bleeding with a score of 0 to continuous bleeding, corresponding to a score of 100." (NCT03783702)
Timeframe: Epistaxis severity will be collected for postoperative day 2

Interventionunits on a scale (Mean)
Experimental Group23.0
Control Group21.6

Severity of Epistaxis

"A 10-cm visual analog scale (VAS) will be used to assess bleeding. The VAS is a continuous, patient-reported outcome measure determined using a horizontal 100-mm scale ranging from no bleeding with a score of 0 to continuous bleeding, corresponding to a score of 100." (NCT03783702)
Timeframe: Epistaxis severity will be collected for postoperative day 3

Interventionunits on a scale (Mean)
Experimental Group15.9
Control Group12.9

Severity of Epistaxis

"A 10-cm visual analog scale (VAS) will be used to assess bleeding. The VAS is a continuous, patient-reported outcome measure determined using a horizontal 100-mm scale ranging from no bleeding with a score of 0 to continuous bleeding, corresponding to a score of 100." (NCT03783702)
Timeframe: Epistaxis severity will be collected for postoperative day 4

Interventionunits on a scale (Mean)
Experimental Group9.3
Control Group11.8

Severity of Epistaxis

"A 10-cm visual analog scale (VAS) will be used to assess bleeding. The VAS is a continuous, patient-reported outcome measure determined using a horizontal 100-mm scale ranging from no bleeding with a score of 0 to continuous bleeding, corresponding to a score of 100." (NCT03783702)
Timeframe: Epistaxis severity will be collected for postoperative day 5

Interventionunits on a scale (Mean)
Experimental Group10.1
Control Group7.8

Severity of Epistaxis

"A 10-cm visual analog scale (VAS) will be used to assess bleeding. The VAS is a continuous, patient-reported outcome measure determined using a horizontal 100-mm scale ranging from no bleeding with a score of 0 to continuous bleeding, corresponding to a score of 100." (NCT03783702)
Timeframe: Epistaxis severity will be collected for postoperative day 6

Interventionunits on a scale (Mean)
Experimental Group6.5
Control Group6.6

Severity of Epistaxis

"A 10-cm visual analog scale (VAS) will be used to assess bleeding. The VAS is a continuous, patient-reported outcome measure determined using a horizontal 100-mm scale ranging from no bleeding with a score of 0 to continuous bleeding, corresponding to a score of 100." (NCT03783702)
Timeframe: Epistaxis severity will be collected for postoperative day 7

Interventionunits on a scale (Mean)
Experimental Group4.6
Control Group5.4

Medication Log

Patients kept a daily medication log and reported the number of doses consumed per day (650mg acetaminophen, 600mg ibuprofen, 5mg oxycodone). The mean number of medication doses per day was calculated for each treatment group. (NCT03783702)
Timeframe: Postoperative day 1 to 7

,
InterventionAverage number of medication doses/day (Mean)
Oxycodone POD1Oxycodone POD2Oxycodone POD3Oxycodone POD4Oxycodone POD5Oxycodone POD6Oxycodone POD7Acetaminophen POD1Acetaminophen POD2Acetaminophen POD3Acetaminophen POD4Acetaminophen POD5Acetaminophen POD6Acetaminophen POD7Ibuprofen POD1Ibuprofen POD2Ibuprofen POD3Ibuprofen POD4Ibuprofen POD5Ibuprofen POD6Ibuprofen POD7
Control Group0.60.40.30.30.30.102.11.91.61.51.31.10.60000000
Experimental Group0.30.10.10.10.10.102.01.81.31.00.90.90.60.60.50.40.30.40.30.2

Number of Participants Who Experienced Postoperative Morbidity (Nausea)

Post-operative nausea will be monitored and measured through direct observation and nursing clinical record (NCT01608308)
Timeframe: During Postoperative Acute Care Unit (PACU) stay (up to 4 hours after surgery)

Interventionparticipants (Number)
IV Acetaminophen13
Control10

Number of Participants Who Received Intraoperative Supplemental Fentanyl

Number of participants who received intraoperative supplemental fentanyl. The decision to administer fentanyl is based on hemodynamic changes, such as increasing blood pressure and heart rate. (NCT01608308)
Timeframe: During Postoperative Acute Care Unit (PACU) stay (up to 4 hours after surgery)

Interventionparticipants (Number)
IV Acetaminophen9
Control4

Postoperative Vital Sign (Diastolic Blood Pressure)

Postoperative vital signs (systolic and diastolic blood pressure, pulse, temperature, and respiratory rate) were measured at different time points up to 4 hours after surgery. (NCT01608308)
Timeframe: During Postoperative Acute Care Unit (PACU) stay (up to 4 hours after surgery)

InterventionmmHg (Mean)
IV Acetaminophen75
Control78.3

Postoperative Vital Sign (Pulse)

Postoperative vital signs (systolic and diastolic blood pressure, pulse, temperature, and respiratory rate) were measured at different time points up to 4 hours after surgery. (NCT01608308)
Timeframe: During Postoperative Acute Care Unit (PACU) stay (up to 4 hours after surgery)

Interventionbeats per minute (Mean)
IV Acetaminophen76.3
Control80

Postoperative Vital Sign (Respiratory Rate)

Postoperative vital signs (systolic and diastolic blood pressure, pulse, temperature, and respiratory rate) were measured at different time points up to 4 hours after surgery. (NCT01608308)
Timeframe: During Postoperative Acute Care Unit (PACU) stay (up to 4 hours after surgery)

Interventionbreaths per minute (Mean)
IV Acetaminophen17.4
Control17.2

Postoperative Vital Sign (Systolic Blood Pressure)

Postoperative vital signs (systolic and diastolic blood pressure, pulse, temperature, and respiratory rate) were measured at different time points up to 4 hours after surgery. (NCT01608308)
Timeframe: During Postoperative Acute Care Unit (PACU) stay (up to 4 hours after surgery)

InterventionmmHg (Mean)
IV Acetaminophen133
Control144

Postoperative Vital Sign (Temperature)

Postoperative vital signs (systolic and diastolic blood pressure, pulse, temperature, and respiratory rate) were measured at different time points up to 4 hours after surgery. (NCT01608308)
Timeframe: During Postoperative Acute Care Unit (PACU) stay (up to 4 hours after surgery)

InterventionFahrenheit (Mean)
IV Acetaminophen97.1
Control97.4

Total Doses of Postoperative Opiate (Morphine) Use

The total amount of morphine utilized in Postoperative Acute Care Unit (PACU) will be recorded. One dose is a 1mg bolus of morphine. (NCT01608308)
Timeframe: During Postoperative Acute Care Unit (PACU) stay (up to 4 hours after surgery)

Interventiondoses (Median)
IV Acetaminophen1.5
Control2.5

Pain Level Assessed Using a Visual Analogue Scale (VAS) Scale

VAS is a validated, self-reported data sheet assessing average pain intensity. Possible scores range from 0 (no pain) to 10 (highest level of pain). (NCT01608308)
Timeframe: 15 minutes and 120 minutes Post-Operatively

,
Interventionunits on a scale (Median)
15 minutes (n=24, 26)120 minutes (n=7, 11)
Control02
IV Acetaminophen00

Trials

6 trials available for acetaminophen and Sinus Infections

ArticleYear
Assessment of Opioid Use and Analgesic Requirements After Endoscopic Sinus Surgery: A Randomized Clinical Trial.
    JAMA otolaryngology-- head & neck surgery, 2021, 09-01, Volume: 147, Issue:9

    Topics: Acetaminophen; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opi

2021
Analgesic Effects of Intravenous Acetaminophen vs Placebo for Endoscopic Sinus Surgery and Postoperative Pain: A Randomized Clinical Trial.
    JAMA otolaryngology-- head & neck surgery, 2017, 08-01, Volume: 143, Issue:8

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Double-Blind Method; Endoscopy; Female; Humans; Infusions,

2017
Comparison of parecoxib and proparacetamol in endoscopic nasal surgery patients.
    Yonsei medical journal, 2008, Jun-30, Volume: 49, Issue:3

    Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Cyclooxygenase Inhibitors; Double-Blind Method; Endo

2008
Role of dexamethasone in reducing pain after endoscopic sinus surgery in adults: a double-blind prospective randomized trial.
    The Annals of otology, rhinology, and laryngology, 2010, Volume: 119, Issue:4

    Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents; Chronic Disease; Dexametha

2010
[Efficacy and tolerability of tiaprofenic acid (Surgam) in acute sinusitis in adults. Results of a randomized study versus paracetamol and placebo].
    Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Societe d'oto-laryngologie des hopitaux de Paris, 1991, Volume: 108, Issue:6

    Topics: Acetaminophen; Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Humans; Placebos; Prop

1991
[Treatment of common cold with a new drug Co-Tylenol].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1972, May-16, Volume: 61, Issue:20

    Topics: Acetaminophen; Adolescent; Adult; Aged; Child; Child, Preschool; Clinical Trials as Topic; Common Co

1972

Other Studies

10 other studies available for acetaminophen and Sinus Infections

ArticleYear
Effect of Over the Counter Ibuprofen Dosing after Sinus Surgery for Chronic Rhinosinusitis: A Prospective Cohort Pilot Study.
    The Annals of otology, rhinology, and laryngology, 2020, Volume: 129, Issue:7

    Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Analgesics, Opioid; Chronic Disease; Cohort St

2020
Tissue Necrosis and Fungal Rhinosinusitis Resulting From Intranasal Acetaminophen Use.
    Ear, nose, & throat journal, 2020, Volume: 99, Issue:10

    Topics: Acetaminophen; Administration, Intranasal; Adult; Female; Humans; Medical Illustration; Mycoses; Nas

2020
Prevalence and risk factors for allergic rhinitis in primary schoolchildren in Budapest.
    International journal of pediatric otorhinolaryngology, 2010, Volume: 74, Issue:5

    Topics: Acetaminophen; Adenoidectomy; Air Pollution; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Asthma

2010
Postoperative pain assessment after functional endoscopic sinus surgery (FESS) for chronic pansinusitis.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2013, Volume: 270, Issue:1

    Topics: Acetaminophen; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; An

2013
Drug eruptions in children with ENT infections.
    International journal of pediatric otorhinolaryngology, 2006, Volume: 70, Issue:1

    Topics: Acetaminophen; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Child; Chi

2006
[Drug esophagitis induced by Rhinasal].
    Presse medicale (Paris, France : 1983), 1983, Jun-25, Volume: 12, Issue:27

    Topics: Acetaminophen; Drug Combinations; Esophagitis; Female; Humans; Phenylpropanolamine; Sinusitis; Ulcer

1983
Acute generalized exanthematous pustulosis associated with paracetamol.
    Acta dermato-venereologica, 1998, Volume: 78, Issue:3

    Topics: Acetaminophen; Acute Disease; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Drug Eruptio

1998
Aspirin and concomitant idiosyncrasies in adult asthmatic patients.
    The Journal of allergy and clinical immunology, 1979, Volume: 64, Issue:6 Pt 1

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adult; Aged; Aspirin; Asthma; Azo Compounds; Drug H

1979
[Clinical observations and analgesic properties of the association of paracetamol and phenylbutazone].
    Revista brasileira de medicina, 1966, Volume: 23, Issue:9

    Topics: Acetaminophen; Back Pain; Contusions; Ear Diseases; Headache; Humans; Joint Diseases; Muscular Disea

1966
Headache.
    The British journal of clinical practice, 1972, Volume: 26, Issue:8

    Topics: Acetaminophen; Anti-Bacterial Agents; Chlordiazepoxide; Headache; Humans; Migraine Disorders; Sinusi

1972